NEUROASPIS
Product description
A NOVEL & PIONEER INTERVENTION FOR MULTIPLE SCLEROSIS WITH CLINICAL STUDY PHASE III
NEUROASPIS is probably the first patented combination and specially formulated dietary supplement in Europe used for medical purposes in order to support the treatment of MS patients in particular and other related neurodegenerative diseases.
Through a diligent examination of the disease’s modus operandi through a systems medicine approach, the ingredients and their relative concentrations were chosen so the cocktail provides the evident neuro-protective benefits.
NEUROASPIS is a product of more than 10 years of research and clinical development, where the Clinical Studies Phase II and Phase III are published in 2013 and 2022 accordingly in BMJ.
Read more
NEUROASPIS is probably the first patented combination and specially formulated dietary supplement in Europe used for medical purposes in order to support the treatment of MS patients in particular and other related neurodegenerative diseases.
Through a diligent examination of the disease’s modus operandi through a systems medicine approach, the ingredients and their relative concentrations were chosen so the cocktail provides the evident neuro-protective benefits.
NEUROASPIS is a product of more than 10 years of research and clinical development, where the Clinical Studies Phase II and Phase III are published in 2013 and 2022 accordingly in BMJ.
Specifications
Categories | Branded Finished Products |
---|---|
Supplied from | Greece |
Product Applications | Dietary Supplements |
Product Certifications | Health & Safety (GMP, HAACP and equivalents) |
Products from other suppliers
❮
❯
-
NaSure Natural Solutions
-
Sunflower HeliaPro Plant-Based Proteins
-
Cardiose
-
EVNol™ - Natural Full Spectrum Tocotrienol/Tocopherol Complex
-
Full fat enzyme active soft soybean flour - Biopro 32
-
TruBeet® - Nitrate Rich Beetroot Extract
-
HYDROVAS 10
-
AvoVida® - Avocado-soy unsaponifiables
-
Solutions for Beverages
-
Care300® - Glucose management
NEUROASPIS